Storytelling, lists, and the role of Catalan final particle i au
Interactional Linguistics · 13.11.2026 · 6 (2) · 125-147
DOI: 10.1075/il.24012.ser ↗Kurz gefasst
Fachartikel in der Zeitschrift Interactional Linguistics, online erschienen am 03.06.2025. Verfasst von Natàlia Server Benetó. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Interactional research into storytelling has focused on the telling, the sequential organization of the narration in the turn-at-talk, while research on lists looks at their structure in interaction. The present study contributes to the scarce work on telling-endings and on generalized list completers by focusing on the grammaticalized Catalan final particle i au . Drawing from a vast corpus of oral narrations in Catalan (58 hours), I show how speakers use i au in narrations to end a series of actions and progress to the rest of the story. In lists, speakers employ i au to put an end to an enumeration of similarly related items, to indicate that no more may be added. Both ending functions are achieved due to a pragmatic resignification of the core meanings of the components of i au . The linking conjunction i facilitates a sequential connection to the last element of the series, and the functional use of au as an interjection contributes in conveying an ending. Consequently, i au appears in structurally similar contexts such as tellings and lists.
Zitieren
APA
Benetó, N. S. (2026). Storytelling, lists, and the role of Catalan final particle i au. Interactional Linguistics, 6(2), 125-147. https://doi.org/10.1075/il.24012.ser
Vancouver
Benetó NS. Storytelling, lists, and the role of Catalan final particle i au. Interactional Linguistics. 2026;6(2):125-147. doi:10.1075/il.24012.ser
BibTeX
@article{Benet2026,
author = {Benetó, Natàlia Server},
title = {Storytelling, lists, and the role of Catalan final particle i au},
journal = {Interactional Linguistics},
year = {2026},
volume = {6},
number = {2},
pages = {125--147},
doi = {10.1075/il.24012.ser}
}
EUVIMED